Research Topics
| C NiederSummaryAffiliation: Nordland Hospital Country: Norway Publications
| Collaborators
|
Detail Information
Publications
Contribution of case reports to brain metastases research: systematic review and analysis of pattern of citationCarsten Nieder
Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway
PLoS ONE 7:e34300. 2012..Apparently, case reports describing unexpected therapeutic success gain more attention, at least in terms of citation, than others...
Adding cetuximab to stereotactic radiotherapy for non-small cell lung cancer might reduce local failure ratesCarsten Nieder
Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway
Med Hypotheses 78:420-2. 2012..If improved local control rates could be observed, overall survival might improve accordingly...
A review of clinical trials of cetuximab combined with radiotherapy for non-small cell lung cancerCarsten Nieder
Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway
Radiat Oncol 7:3. 2012..Nevertheless, combined treatment appears feasible. The role of consolidation cetuximab after RT is uncertain. A large randomised phase III study of combined RT, chemotherapy and cetuximab has been initiated...
Combined radio- and chemotherapy of brain tumours in adult patientsC Nieder
Radiation Oncology Unit, Nordland Hospital, Bodø, Norway
Clin Oncol (R Coll Radiol) 21:515-24. 2009..The challenges associated with brain tumour treatment remain formidable, but rationally designed clinical trials are gradually leading to improved outcomes...
Improvement, clinical course, and quality of life after palliative radiotherapy for recurrent glioblastomaCarsten Nieder
Department of Internal Medicine Oncology and Radiation Oncology Units, Nordlandssykehuset HF, Bodø, Norway
Am J Clin Oncol 31:300-5. 2008..Salvage chemotherapy or targeted agents should be prospectively tested against re-irradiation alone...
Disease presentation and treatment outcome in very young patients with brain metastases from lung cancerCarsten Nieder
Radiation Oncology Unit, Nordlandssykehuset HF, Bodø, Norway
Onkologie 31:305-8. 2008..While elderly patients with brain metastases from lung cancer appear to have an unfavorable prognosis, little information is available on disease presentation and treatment outcome in very young patients...
Presentation and course of brain metastases from breast cancer in a paranoid-schizophrenic patient: A case reportAstrid Dalhaug
Radiation Oncology Unit, Medical Department, Nordlandssykehuset HF, 8092 Bodø, Norway
Cases J 1:195. 2008..Treatment consisted of whole-brain radiotherapy and letrozole. Twenty-one months later, the patient is in continued partial remission...
Effects of smoking cessation on hypoxia and its potential impact on radiation treatment effects in lung cancer patientsCarsten Nieder
Radiation Oncology Unit, Medical Department, Nordlandssykehuset HF, Bodø, Norway
Strahlenther Onkol 184:605-9. 2008....
Validation of the graded prognostic assessment index for surgically treated patients with brain metastasesCarsten Nieder
Medical Department, Radiation Oncology Unit, Nordlandssykehuset HF, Bodø, Norway
Anticancer Res 28:3015-7. 2008..9, 9.8, 5.5, and 3.7 months, respectively (p<0.05). In conclusion, these results confirm the validity of the GPA index in a patient population that previously has not been assessed with this new tool...
Disease presentation and outcome in young patients (<40 years) with brain metastases from malignant melanomaCarsten Nieder
Medical Department Oncology, Nordlandssykehuset HF, Bodø, Norway
Anticancer Res 28:1325-7. 2008..Whole-brain radiation therapy was not able to provide durable CNS control. Prospective studies on treatment intensification appear warranted...
Prediction of very short survival in patients with brain metastases from breast cancerC Nieder
Radiation Oncology Unit, Nordlandssykehuset HF, 8092 Bodø, Norway
Clin Oncol (R Coll Radiol) 20:337-9. 2008..e. <2 months, who are unlikely to derive major benefit from whole brain radiotherapy. Our aim was to develop a more reliable model...
Is whole-brain radiotherapy effective and safe in elderly patients with brain metastases?Carsten Nieder
Radiation Oncology Unit, Nordlandssykehuset HF, Bodø, Norway
Oncology 72:326-9. 2007..The outcome of whole-brain radiotherapy in elderly patients with brain metastases is not well documented. As the number of such patients is expected to increase, we evaluated our results...
An uncommon presentation and course of metastatic malignant melanoma: a case reportAstrid Dalhaug
Radiation Oncology Unit, Department of Internal Medicine and Skin Diseases, Nordlandssykehuset HF, 8092 Bodø, Norway
J Med Case Reports 1:151. 2007..This case illustrates that some patients with multi-organ melanoma manifestations may benefit from the repeated use of effective local therapeutic approaches and may experience a quite favourable prognosis...
The role of postoperative radiotherapy after resection of a single brain metastasis. Combined analysis of 643 patientsCarsten Nieder
Radiation Oncology Unit, Department of Internal Medicine, Nordlandssykehuset HF, Bodø, Norway
Strahlenther Onkol 183:576-80. 2007....
Detrimental effects of an antibody directed against tumor necrosis factor alpha in experimental kidney irradiationCarsten Nieder
Department of Internal Medicine Oncology, Radiation Oncology Unit, Nordlandssykehuset HF, Bodø, Norway
Anticancer Res 27:2353-7. 2007..These data suggest that administration of infliximab concomitant to radiotherapy causes profound alterations in the development of kidney dysfunction. Importantly, other radiation-related toxicities were similar across all groups...
Analysis of long-term survivors of glioblastoma multiforme in a single institution with aggressive local retreatment protocolCarsten Nieder
Radiation Oncology Unit, Nordlandssykehuset HF, 8092 Bodo, Norway
Anticancer Res 27:2993-6. 2007..Our institution has used an aggressive policy of local retreatment, including surgery and radiotherapy, at first relapse. Long-term survival (>2 years) after such an approach was evaluated...
Experimental concepts for toxicity prevention and tissue restoration after central nervous system irradiationCarsten Nieder
Radiation Oncology Unit, Nordlandssykehuset HF, 8092 Bodø, Norway
Radiat Oncol 2:23. 2007....
Evaluation of late neurologic adverse events in patients with brain metastases from non-small cell lung cancerCarsten Nieder
Department of Internal Medicine Oncology, Radiation Oncology Unit, Nordlandssykehuset HF, Bodø, Norway
Anticancer Res 27:1701-4. 2007....
Disease presentation and outcome in very young patients with brain metastases from breast cancerCarsten Nieder
Radiation Oncology Unit, Department of Internal Medicine, Nordlandssykehuset HF, Bodø, Norway
Tumori 94:691-3. 2008..Little information is available on disease presentation and treatment outcome in very young patients with brain metastases from breast cancer. Therefore, we evaluated our results in this group...
Colorectal cancer metastatic to the brain: time trends in presentation and outcomeCarsten Nieder
Department of Internal Medicine, Division of Oncology and Palliative Medicine, Nordlandssykehuset HF, Bodø, Norway
Oncology 76:369-74. 2009..It was the aim of this study to compare differences in disease pattern, patient characteristics and survival in patient cohorts treated during different decades...
Prognostic scores in brain metastases from breast cancerCarsten Nieder
Radiation Oncology Unit, Nordlandssykehuset HF, Bodø, Norway
BMC Cancer 9:105. 2009..The available scores for patients with brain metastases have never been tested specifically in patients with primary breast cancer. It is therefore unknown which score is most appropriate for these patients...
A population-based study of the pattern of terminal care and hospital death in patients with non-small cell lung cancerCarsten Nieder
Department of Oncology and Palliative Medicine, Nordland Hospital, P O Box 1480, 8092 Bodø, Norway
Anticancer Res 32:189-94. 2012..Patients with T4 tumors might experience unsatisfactory symptom control and should be offered a part in prospective studies addressing these issues...
Comorbidity, use of common medications, and risk of early death in patients with localized or locally advanced prostate cancerCarsten Nieder
Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway
ScientificWorldJournal 11:1178-86. 2011..Our data suggest that simple parameters such as use of medications vs. none, or presence of serious cardiac disease vs. none, are not sufficient, and that age-adjusted CCI scores outperform the other factors included in our analysis...
Impact of common medications on serum total prostate-specific antigen levels and risk group assignment in patients with prostate cancerCarsten Nieder
Department of Oncology and Palliative Medicine, Nordland Hospital, Bodo, Norway
Anticancer Res 31:1735-9. 2011..These results support the concerns expressed previously, given that risk group assignment, which may be inaccurate in patients using concomitant medications, eventually guides choice of treatment...
Can current prognostic scores reliably guide treatment decisions in patients with brain metastases from malignant melanoma?Carsten Nieder
Department of Oncology and Palliative Medicine, Radiation Oncology Unit, Nordland Hospital, Bodø, Norway
J Cancer Res Ther 7:47-51. 2011....
Pathologic fracture and metastatic spinal cord compression in patients with prostate cancer and bone metastasesCarsten Nieder
Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway
BMC Urol 10:23. 2010..The purpose of this study was to determine the risk factors for and incidence as well as prognostic impact of pathologic fracture (PF) and metastatic spinal cord compression (MSCC) in patients with bone metastases (BM) from prostate cancer...
Advances in translational research provide a rationale for clinical re-evaluation of high-dose radiotherapy for glioblastomaCarsten Nieder
Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway
Med Hypotheses 76:410-3. 2011..Additional drugs targeting other pathways and microenvironmental features such as invasion, oxygenation and blood supply, might be included in the rational design of future clinical trials, provided initial studies support their use...
Resource utilization in patients with brain metastases managed with best supportive care, radiotherapy and/or surgical resection: a Markov analysisCarsten Nieder
Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway
Oncology 78:348-55. 2010..In spite of the large number of patients and increasing financial pressure on health care budgets worldwide, limited data on resource utilization after diagnosis of brain metastases are available...
A new prognostic score derived from phase I study participants with advanced solid tumours is also valid in patients with brain metastasisCarsten Nieder
Radiation Oncology Unit, Department of Oncology and Palliative Medicine, Nordland Hospital, 8092 Bodø, Norway
Anticancer Res 30:977-9. 2010..Its performance should be evaluated in larger groups of patients and head to head comparisons of the established brain metastases scores with this new model should be made...
Validation of new prognostic and predictive scores by sequential testing approachCarsten Nieder
Radiation Oncology Unit, Department of Oncology and Palliative Care, Nordland Hospital, Bodø, Norway
Strahlenther Onkol 186:169-73. 2010..The present study evaluates this approach in scores related to radiation oncology...
Treatment of brain metastases from renal cell cancerCarsten Nieder
Department of Internal Medicine, Division of Oncology, Nordland Hospital, Bodø, Norway
Urol Oncol 29:405-10. 2011..To evaluate disease pattern, patient characteristics, and survival in patients treated for brain metastases from renal cell carcinoma...
Prediction of short survival in patients with brain metastases based on three different scores: a role for 'triple-negative' status?C Nieder
Radiation Oncology Unit, Nordland Hospital, Bodø, Norway Institute of Clinical Medicine, Faculty of Medicine, University of Tromsø, Tromsø, Norway
Clin Oncol (R Coll Radiol) 22:65-9. 2010..To evaluate models predicting short survival in patients with brain metastases treated with whole-brain radiotherapy (WBRT)...
Prognostic scores in patients with brain metastases from non-small cell lung cancerCarsten Nieder
Radiation Oncology Unit, Department of Internal Medicine Oncology, Nordland Hospital, Bodø, Norway
J Thorac Oncol 4:1337-41. 2009..No comparison to the two NSCLC-specific scores has been made either. Hence, it remains unclear which score is most appropriate for these patients...
Does distance to treatment centre influence the rate of palliative radiotherapy in adult cancer patients?Carsten Nieder
Radiation Oncology Unit, Department of Internal Medicine, Nordlandssykehuset HF, 8092 Bodø, Norway
Anticancer Res 29:2641-4. 2009..In conclusion, these data suggest that the utilisation of palliative radiotherapy in a health care system without financial barriers to treatment no longer varies with distance between residence and hospital...
Estimating need for palliative external beam radiotherapy in adult cancer patientsCarsten Nieder
Division of Hematology and Oncology, Department of Internal Medicine, Nordlandssykehuset HF Hospital, Bodø, Norway
Int J Radiat Oncol Biol Phys 76:207-11. 2010..The corresponding number for Norway was 95 (95% CI 93-98) in 2004. New data are lacking, although new systemic treatment options might alter this number...
Influence of different treatment techniques on radiation dose to the LAD coronary arteryCarsten Nieder
Radiation Oncology Unit, Nordlandssykehuset HF, 8092 Bodø, Norway
Radiat Oncol 2:20. 2007..Radiation-induced heart disease might be a serious complication in long-term cancer survivors...
Radiation therapy plus angiogenesis inhibition with bevacizumab: rationale and initial experienceCarsten Nieder
Radiation Oncology Unit, Department of Internal Medicine and Skin Diseases, Nordlandssykehuset HF, 8092 Bodø, Norway
Rev Recent Clin Trials 2:163-8. 2007..Early results suggest that acute toxicity is acceptable, planned surgery after such treatment is feasible, and that further evaluation of such combined modality treatment is warranted...
Postoperative treatment and prognosis of patients with resected single brain metastasis: how useful are established prognostic scores?Carsten Nieder
Department of Oncology and Palliative Medicine, Nordland Hospital, 8092 Bodø, Norway
Clin Neurol Neurosurg 113:98-103. 2011..To evaluate postoperative prognosis and the performance of known prognostic scores in patients treated with surgical resection for single brain metastasis...
Does overall treatment time impact on survival after whole-brain radiotherapy for brain metastases?C Nieder
Department of Oncology and Palliative Medicine, Nordland Hospital, Bodo, Norway
Clin Transl Oncol 13:885-8. 2011..While survival might be largely independent from OTT, it should also be evaluated whether this parameter has any impact on quality of life and duration of palliation...
Sunitinib, sorafenib, temsirolimus or bevacizumab in the treatment of metastatic renal cell carcinoma: a review of health economic evaluationsJ Norum
Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, Norway
J Chemother 22:75-82. 2010..When compared to the other agents, sunitinib has the best cost-effectiveness figure. Second-line therapy does not offer valid incremental cost-effectiveness ratios...
Leptomeningeal carcinomatosis from renal cell cancer: treatment attempt with radiation and sunitinib (case report)Astrid Dalhaug
Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway
World J Surg Oncol 8:36. 2010..The untreated lung metastases progressed very slowly during almost 3 years of observation. This case illustrates important issues around both biological behaviour and treatment approaches in metastatic renal cell cancer...
Anaemia and thrombocytopenia in patients with prostate cancer and bone metastasesCarsten Nieder
Department of Internal Medicine Division of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway
BMC Cancer 10:284. 2010..The purpose of this study was to determine the incidence, risk factors and prognostic impact of anaemia and thrombocytopenia in patients with bone metastases (BM) from prostate cancer...
Validation of the graded prognostic assessment index for patients with brain metastasesCarsten Nieder
Medical Department, Radiation Oncology Unit, Nordlandssykehuset HF, Bodø, Norway
Acta Oncol 48:457-9. 2009....
Can prophylactic breast irradiation contribute to cardiac toxicity in patients with prostate cancer receiving androgen suppressing drugs?Carsten Nieder
Radiation Oncology Unit, Nordlandssykehuset HF, 8092 Bodø, Norway
Radiat Oncol 3:2. 2008..Possible explanations were provided, however, they disregard the potential contribution of prophylactic radiotherapy to the mamillary regions (PMRT, prescribed to avoid gynecomastia)...
Late residual gamma-H2AX foci in murine spinal cord might facilitate development of response-modifying strategies: a research hypothesisNicolaus Andratschke
Department of Radiation Oncology, Klinikum rechts der Isar der Technischen Universitat Munchen, Munich, Germany
Anticancer Res 31:561-4. 2011..A rapid and reliable animal model would allow for screening of a large number of candidate drugs that might modify the radiation response of the spinal cord...
Prognostic indices for brain metastases--usefulness and challengesCarsten Nieder
Medical Department, Division of Oncology, Nordland Hospital, 8092 Bodø, Norway
Radiat Oncol 4:10. 2009..e. between 1997 and 2008. In addition, other analyses of prognostic factors in groups of patients, which typically are underrepresented in large trials or databases, published in the same time period are reviewed...
Radiation therapy alone as an alternative to surgery in patients with early stage non-small-cell lung cancer having cardiovascular (and other) comorbidityBranislav Jeremic
Eur J Cardiothorac Surg 25:297. 2004
Brain metastases in renal cell cancer: diagnostic and therapeutic aspectsCarsten Nieder
Department of Radiation Oncology, Klinikum rechts der Isar, Technical University Munich, Ismaninger Str 22, 81675 Munich, Germany
Am J Clin Oncol 27:632-4. 2004..However, further work-up revealed abscesses from bronchopneumonia. Diagnostic and therapeutic aspects as well as potential pitfalls in the management of patients with brain metastases are discussed...
Dose to the intracranial arteries in stereotactic and intensity-modulated radiotherapy for skull base tumorsCarsten Nieder
Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Int J Radiat Oncol Biol Phys 64:1055-9. 2006..To examine retrospectively the maximum dose to the large skull base/intracranial arteries in fractionated stereotactic radiotherapy (FSRT) and intensity-modulated radiotherapy (IMRT), because of the potential risk of perfusion disturbances...
Acceleration of normal-tissue damage expression by early stimulation of cell proliferation in rat spinal cordCarsten Nieder
Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Strasse 22, 81675 Munich, Germany
Strahlenther Onkol 182:680-4. 2006..To examine experimental strategies for prevention of radiation-induced late spinal cord damage...
Comparison of serum growth factors and tumor markers as prognostic factors for survival in non-small cell lung cancerCarsten Nieder
Department of Radiation Oncology, Klinikum rechts der Isar, Technical University Munich, Ismaninger Str 22, 81675 Munich, Germany
Anticancer Res 23:5117-23. 2003..In virtually all large studies with multivariate analysis, their influence was higher than that of emerging factors...
Treatment of unresectable glioblastoma multiformeCarsten Nieder
Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, 81675 Munich, Germany
Anticancer Res 25:4605-10. 2005..Recent data suggest that class prediction models, based on defined molecular profiles, and assessment of MGMT promoter methylation might contribute to improved patient stratification and decision making...
Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastasesCarsten Nieder
Department of Radiotherapy and Radiologic Oncology, Klinikum rechts der Isar, Technical University of Munich, Germany
Strahlenther Onkol 179:16-20. 2003..If up to three brain metastases are present, surgical resection or radiosurgery are currently being considered in case of favorable prognostic factors...
Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapyAnca L Grosu
Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Strasse 22, 81675 Munich, Germany
Int J Radiat Oncol Biol Phys 63:511-9. 2005..To develop a valid treatment strategy for recurrent high-grade gliomas using stereotactic hypofractionated reirradiation based on biologic imaging and temozolomide...
Simultaneous precise chemoradiation under inhalation anesthesia in an experimental mouse tumor modelMarkus Adam
Radiotherapy Practice Weilheim, , 82362 Weilheim, Germany
Anticancer Res 25:2815-20. 2005..Our system allows easy and fast handling and immobilization and thus reduces experimental times...
Combined modality treatment of glioblastoma multiforme: the role of temozolomideCarsten Nieder
Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Str 22, 81675 Munich, Germany
Rev Recent Clin Trials 1:43-51. 2006..The optimum schedule of temozolomide administration and the influence of combinations with additional antineoplastic agents remains to be studied. Early results of clinical trials addressing these issues are presented...
Preclinical evaluation of erythropoietin administration in a model of radiation-induced kidney dysfunctionNicolaus Andratschke
Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Int J Radiat Oncol Biol Phys 64:1513-8. 2006..Although insulin-like growth factor-1 has previously been shown to protect the kidney, such an effect could not be demonstrated for EPO. The latter agent even increased the development of nephropathy...
Comparison of three different mediastinal radiotherapy techniques in female patients: Impact on heart sparing and dose to the breastsCarsten Nieder
Department of Radiation Oncology, Klinikum rechts der Isar der Technischen Universitat Munchen, Munich, Germany
Radiother Oncol 82:301-7. 2007..Especially in highly curable diseases such as lymphoma, long-term survivors might develop late cardiac damage and radiation-induced second cancer...
Extensive local and systemic therapy in extraneural metastasized glioblastoma multiformeSabrina T Astner
Department of Radiation Oncology, Technical University of Munich, Germany
Anticancer Res 26:4917-20. 2006..In conclusion, liver metastases of GBM can be effectively treated by chemotherapy. This case report suggests suitable substances which can be chosen according to clinical circumstances...
Necessity of identifying the patterns of failure after concurrent radiochemotherapy part of a combined modality approach in patients with stage III non-small cell lung cancer [Sakai et al., Lung Cancer 2004;43:195-201]Branislav Jeremic
Lung Cancer 46:263-4. 2004
Evaluation of insulin-like growth factor-1 in a mouse model of long-term abdominal radiation toxicityCarsten Nieder
Department of Radiation Oncology, Klinikum rechts der Isar der Technischen Universitat Munchen, Munich, Germany
Anticancer Res 27:183-7. 2007....
Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC)Frank B Zimmermann
Department of Radiation Oncology, Klinikum rechts der Isar, Technical University, Munich, FRG
Acta Oncol 45:796-801. 2006..Hypofractionated SRT is safe even in elderly patients with stage I NSCLC and significantly reduced lung capacity. It leads to high local control rates and should be offered to patients not amenable for curative resection...
Glioma treatment, radionecrosis, and growth factors. In regard to Levin et al., IJROBP 2002;53:58-66Carsten Nieder
Int J Radiat Oncol Biol Phys 55:849; author reply 849. 2003
Treatment of newly diagnosed glioblastoma multiformeCarsten Nieder
J Clin Oncol 20:3179-80; author reply 3181-2. 2002
Tirapazamine plus cisplatin and irradiation in a mouse model: improved tumor control at the cost of increased toxicityMarkus Adam
Radiotherapy Practice Weilheim, Weilheim, Germany
J Cancer Res Clin Oncol 134:137-46. 2008..Tirapazamine (TPZ) reportedly enhances the tumor cell killing effect of cisplatin up to fivefold and it is an attractive drug for combination with radiotherapy. We evaluated the toxicity of a fractionated combined treatment...
High-precision radiation therapy with integrated biological imaging and tumor monitoring: evolution of the Munich concept and future research optionsAnca L Grosu
Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Germany
Strahlenther Onkol 182:361-8. 2006..Temporal changes in tumor biology, which might represent both a challenge and a chance with regard to adaptation of treatment, need to be addressed in greater detail...
[Evaluation of the toxicity of tirapazamine plus cisplatin in a mouse tumor model]Markus Adam
Praxis für Strahlentherapie und Radioonkologie, Röntgenstrasse 4, 82362 Weilheim
Strahlenther Onkol 182:231-9. 2006..The authors evaluated the toxicity of TPZ in combination with cisplatin in a mouse tumor model. For this purpose, general toxicity was monitored and all inner organs were examined histologically...
Current status of angiogenesis inhibitors combined with radiation therapyCarsten Nieder
Department of Radiation Oncology, Klinikum rechts der Isar der Technischen Universitat Munchen, Ismaninger Str 22, 81675 Munich, Germany
Cancer Treat Rev 32:348-64. 2006..Early results suggest that acute toxicity is acceptable, planned surgery after such treatment is feasible, and that further evaluation of such combined modality treatment is warranted...
What approach will lead to cure of glioblastoma multiforme? In regard to Barani et al. (Int J Radiat Oncol Biol Phys 2007;68:324-333) and Jones and Sanghera (Int J Radiat Oncol Biol Phys 2007;68:441-448)Carsten Nieder
Int J Radiat Oncol Biol Phys 69:640-1; author reply 641. 2007
Immunohistochemically detected p53 mutations in epithelial tumors and results of treatment with chemotherapy and radiotherapy. A treatment-specific overview of the clinical dataHoward D Thames
Department of Biomathematics, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Strahlenther Onkol 178:411-21. 2002..a nearly significant negative effect of p53 overexpression on outcome of treatment with cytotoxic drugs and radiation emerges in the few studies where heterogeneity can be sufficiently reduced or accounted for...
Influence of whole-brain radiotherapy on remission of brain metastasesCarsten Nieder
J Clin Oncol 24:4037; author reply 4037-8. 2006
Retreatment of the spinal cord with palliative radiotherapyAnca-Ligia Grosu
Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Int J Radiat Oncol Biol Phys 52:1288-92. 2002..However, for the purpose of palliation, retreatment within the dose range used at our institution should be considered, taking the patient's expected life span and clinical symptoms into account...
[Experimental data for administration of insulin-like growth factor 1 (IGF-1) and basic fibroblast growth factor (bFGF) for prevention of radiation myelopathy]Carsten Nieder
Klinik und Poliklinik für Strahlentherapie und Radiologische Onkologie, Technische Universitat, Klinikum rechts der Isar, Munchen
Strahlenther Onkol 178:147-52. 2002..Thus, we tested whether insulin-like growth factor-1 (IGF-1) and basic fibroblast growth factor (bFGF) alone or in combination modulate radiation tolerance of the rat cervical spinal cord...
Radiotherapy-induced lung toxicity: risk factors and prevention strategiesCarsten Nieder
Department of Radiation Oncology, Klinikum rechts der Isar, Technical University Munich, Ismaninger Str 22, 81675 Munich, Germany
Anticancer Res 23:4991-8. 2003..This review summarizes translational research data as well as clinical strategies for response modification and prediction...
Update of human spinal cord reirradiation tolerance based on additional data from 38 patientsCarsten Nieder
Department of Radiation Oncology, Klinikum rechts der Isar der Technischen Universitat Munchen, Munich, Germany
Int J Radiat Oncol Biol Phys 66:1446-9. 2006..To update a combined analysis of all published clinical data...
Implications of IMT-SPECT for postoperative radiotherapy planning in patients with gliomasAnca Ligia Grosu
Klinik und Poliklinik für Strahlentherapie und Radiologische Onkologie, Klinikum rechts der Isar, Technische Universitat Munchen, Munchen, Germany
Int J Radiat Oncol Biol Phys 54:842-54. 2002..The goal of this study was to analyze the value of 123I-alpha-methyl-tyrosine-single photon emission CT (IMT-SPECT) in radiotherapy planning of patients with brain gliomas after surgical resection...
Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?Carsten Nieder
Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Germany
Strahlenther Onkol 180:401-7. 2004..e., application of more than one fraction per day, in high-grade gliomas. This review summarizes the results of trials published between January 1997 and June 2002...
Modulation of rodent spinal cord radiation tolerance by administration of platelet-derived growth factorNicolaus H Andratschke
Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
Int J Radiat Oncol Biol Phys 60:1257-63. 2004..They form the basis for further studies of growth factor administration in this particular model...
Carcinomatous meningitis appearing as acoustic neuromas: two casesSabrina T Astner
Department of Radiation Oncology, Technical University of Munich, Germany
Strahlenther Onkol 183:279-83. 2007..If medical history does not match with acoustic neuroma, further diagnostics are necessary to rule out infectious disease or carcinomatous meningitis...
Therapeutic options for recurrent high-grade glioma in adult patients: recent advancesCarsten Nieder
Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Str 22, 81675 Munich, Germany
Crit Rev Oncol Hematol 60:181-93. 2006..Individual tailoring of such strategies based on molecular profiling is hoped to improve the outcome...
11C-methionine PET improves the target volume delineation of meningiomas treated with stereotactic fractionated radiotherapyAnca Ligia Grosu
Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Int J Radiat Oncol Biol Phys 66:339-44. 2006..To evaluate the role of 11C-methionine positron emission tomography (MET-PET) in target volume delineation for meningiomas and to determine the interobserver variability...
Does prophylactic breast irradiation in patients with prostate cancer influence cardiac toxicity?Carsten Nieder
J Natl Cancer Inst 99:1646-7. 2007
Re-irradiation for recurrent head and neck cancer: in regard to Lee et Al. (Int j radiat oncol biol phys 2007;68:731-740)Carsten Nieder
Int J Radiat Oncol Biol Phys 69:1652-3; author reply 1653. 2007
Effects of insulin-like growth factor-1 (IGF-1) and amifostine in spinal cord reirradiationCarsten Nieder
Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Germany
Strahlenther Onkol 181:691-5. 2005..Because of different modes of action, a follow-up study was undertaken to test the combined treatment...
The role of pentoxifylline as a modifier of radiation therapyCarsten Nieder
Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Str 22, 81675 Munich, Germany
Cancer Treat Rev 31:448-55. 2005..It is therefore necessary to evaluate Ptx in larger clinical trials with less baseline variation and to improve the recording of long-term results...
Effects of radiotherapy and chemotherapy on sensory deficits from spinal cord damageCarsten Nieder
Acta Oncol 44:412-4. 2005
L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapyAnca Ligia Grosu
Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Int J Radiat Oncol Biol Phys 63:64-74. 2005..The goal of this trial was to quantify the affect of MET-PET vs. with MRI in gross tumor volume definition for radiotherapy planning of high-grade gliomas...
Evaluation of insulin-like growth factor-1 for prevention of radiation-induced spinal cord damageCarsten Nieder
Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Growth Factors 23:15-8. 2005....
Potential role of growth factors in diminishing radiation therapy neural tissue injuryNicolaus H Andratschke
Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Semin Oncol 32:S67-70. 2005..Additional investigation is required to define potentially clinically useful growth factor regimens in the clinic...
Treatment of malignant gliomas: radiotherapy, chemotherapy and integration of new targeted agentsCarsten Nieder
Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Str 22, 81675 Munich, Germany
Expert Rev Neurother 4:691-703. 2004..e., drugs, antibodies and antisense oligonucleotides) have now entered clinical trials, mainly for recurrent gliomas and a small number are being tested in combination with radiotherapy. Early results of such approaches are presented...
Radiotherapy and chemotherapy for myoepithelioma of the sellar regionCarsten Nieder
Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Germany
Strahlenther Onkol 181:260-3. 2005..Myoepithelioma might arise in the head and neck area, especially within the salivary glands. It is very uncommon as a primary intracranial tumor...
Prevention of radiation-induced central nervous system toxicity: a role for amifostine?Carsten Nieder
Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Str 22, 81765 Munich, Germany
Anticancer Res 24:3803-9. 2004..To review the role of amifostine (WR-2721) in ameliorating radiation-induced central nervous system (CNS) toxicity...
Proposal of human spinal cord reirradiation dose based on collection of data from 40 patientsCarsten Nieder
Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Strasse 22, 81675 Munich, Germany
Int J Radiat Oncol Biol Phys 61:851-5. 2005..However, prospective clinical studies are lacking. Therefore, a combined analysis of all published clinical data might provide a valuable basis for future trials...
Salvage radiotherapy in patients with PET-Positive residual non-Hodgkin's lymphoma after chemotherapy: in regard to Kahn et al. (Int J Radiat Oncol Biol Phys 2006;66:961-965)Carsten Nieder
Int J Radiat Oncol Biol Phys 67:1278; author reply 1278. 2007
